Kawasaki, Japan

Manami Shuto



Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Manami Shuto

Introduction

Manami Shuto is a prominent inventor based in Kawasaki, Japan. She has made significant strides in the field of medicinal chemistry, particularly with her innovative work on sulfonamide derivatives. Her contributions have the potential to impact the pharmaceutical industry positively.

Latest Patents

Manami Shuto holds a patent for a sulfonamide derivative and its medicinal use. This patent describes sulfonamide compounds characterized by a specific chemical structure, where a sulfonamide group is substituted with a phenyl group or a heterocyclic group containing hetero atoms. These novel compounds exhibit excellent α4 integrin-inhibitory action, making them valuable in therapeutic applications. The patent also covers pharmaceutically acceptable salts of these compounds.

Career Highlights

Throughout her career, Manami Shuto has demonstrated a commitment to advancing medicinal chemistry. Her work at Ea Pharma Co., Ltd. has positioned her as a key player in the development of innovative pharmaceutical solutions. With her expertise, she has contributed to the creation of compounds that may lead to new treatments for various medical conditions.

Collaborations

Manami has collaborated with notable colleagues, including Hirokazu Ueno and Takashi Yamamoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medicinal research.

Conclusion

Manami Shuto's contributions to the field of medicinal chemistry through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…